GlaxoSmithKline Pushing Dangerous Avandia Drug on Thousands in New Global Clinical Trial (opinion)
Back in February, I wrote an article about how a Senate Finance Committee report revealed that GlaxoSmithKline, the maker of the diabetes drug Avandia, knew that its drug was dangerous and caused heart attacks; yet GSK went out of its way to hide this important information from the public and kept on selling Avandia. Now, [...]
